Agringenium Innovations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 85.00 K
as on 03-07-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 393.74%
(FY 2022)
- Profit 1259.76%
(FY 2022)
- Ebitda -340.04%
(FY 2022)
- Net Worth 296.99%
(FY 2022)
- Total Assets 66.92%
(FY 2022)
About Agringenium Innovations
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 85.00 K , as per Ministry of Corporate Affairs (MCA) records.
Ravikrishna Bhat, Sriramulu Balaji, Narendra Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U93000KA2018PTC113687
- Company No.
113687
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Agringenium Innovations?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Jonnalagadda  | Director | 05-Jun-2018 | Current |
| Ravikrishna Bhat | Director | 05-Jun-2018 | Current |
| Sriramulu Balaji | Director | 05-Jun-2018 | Current |
| Narendra Reddy | Director | 05-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Agringenium Innovations.
Agringenium Innovations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 393.74% increase. The company also saw a substantial improvement in profitability, with a 1259.76% increase in profit. The company's net worth Soared by an impressive increase of 296.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agringenium Innovations?
In 2021, Agringenium Innovations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Impact Engineering Solutions Private LimitedActive 22 years 7 monthsRavikrishna Bhat is a mutual person
- Infodoct Healthcare Solutions Private LimitedActive 6 years 5 months
Ravikrishna Bhat is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Agringenium Innovations?
Unlock and access historical data on people associated with Agringenium Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agringenium Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agringenium Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
